Zura Bio Limited - Class A Ordinary shares — Statistiques financières trimestrielles (NASDAQ:ZURA) | MetaTrader

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques

Trimestriel Annuel

Flux de trésorerie liés aux activités d'exploitation -10.82 M-11.06 M-16.03 M-15.44 M-22.28 M-18.92 M -72.67 M Flux de trésorerie liés aux activités d'investissement -45 K-49 K-15 K-32 K-17 K-13 K -77 K Flux de trésorerie liés aux activités de financement -854 K5.18 M-34 K3 000-7.32 M135.12 M 127.78 M Flux de trésorerie disponible -10.82 M-11.06 M-16.05 M-15.48 M-22.3 M-18.94 M -72.75 M

Nouvelles

Zura Bio nomme Muzammil Mustufa au poste de directeur commercial

Stock Picks From Seeking Alpha's March 2026 New Analysts

Progress Software Posts Upbeat Q4 Earnings, Joins ServisFirst Bancshares, Zura Bio And Other Big Stocks Moving Higher On Wednesday - American Resources (NASDAQ:AREC), ARM Holdings (NASDAQ:ARM)

Worthington Steel, Immunitybio, Riot Platforms, Micron Technology And Other Big Stocks Moving Higher On Friday - Ambarella (NASDAQ:AMBA), AST SpaceMobile (NASDAQ:ASTS)

Zura Bio expands HS trial, delays data readout to fourth quarter 2026

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Autolus Therapeutics (NASDAQ:AUTL), Brand Engagement Network (NASDAQ:BNAI)

DigitalBridge Group, Eightco Holdings, Palisade Bio And Other Big Stocks Moving Higher On Monday - Autolus Therapeutics (NASDAQ:AUTL), DigitalBridge Gr (NYSE:DBRG)

H.C. Wainwright reiterates Neutral rating on Zura Bio stock amid BAFF inhibitor concerns

Zura Bio names Eric Hyllengren as new CFO, effective July 7

Zura Bio to Present at the Jefferies Global Healthcare Conference

Zura Bio begins phase 2 trial for hidradenitis suppurativa treatment